Catalysts for Mayne Pharma Group Ltd
6 tracked
Feb 12, 2026
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Feb 15, 2024
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Dec 28, 2021
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Jun 22, 2021
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Jun 22, 2021
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→
Oct 28, 2018
approval
BIJUVA (ESTRADIOL) — FDA approval
(estradiol + progesterone)
→